The Clinical Studies Quality Committee (CSQC) provides UHN-wide leadership for patient safety and best practice in clinical research. It reports to the Quality Committee of the Board and is chaired by Dr. Charles Chan (Interim President & CEO and EVP & Chief Medical Officer) and Dr. Bradly Wouters (EVP, Science and Research).